Impact of the first 5 years of a national abdominal aortic aneurysm screening programme

2016 ◽  
Vol 103 (9) ◽  
pp. 1125-1131 ◽  
Author(s):  
J. Jacomelli ◽  
L. Summers ◽  
A. Stevenson ◽  
T. Lees ◽  
J. J. Earnshaw
Keyword(s):  
Abdominal Aortic Aneurysm ◽  
Aortic Aneurysm ◽  
Screening Programme ◽  
Abdominal Aortic

scholarly journals Outcomes in Men From the NHS Abdominal Aortic Aneurysm Screening Programme With a Large Aneurysm Referred for Intervention

2021 ◽  
Vol 73 (3) ◽  
pp. 1108
Author(s):  
L. Meecham ◽  
J. Jacomelli ◽  
M. Davis ◽  
A. Pherwani ◽  
T. Lees ◽  
...  
Keyword(s):  
Abdominal Aortic Aneurysm ◽  
Aortic Aneurysm ◽  
Screening Programme ◽  
Abdominal Aortic ◽  
Large Aneurysm

Abdominal aortic aneurysm screening programme

2019 ◽  
Vol 13 (9) ◽  
pp. 430-434
Author(s):  
Ian Peate
Keyword(s):  
Abdominal Aortic Aneurysm ◽  
Aortic Aneurysm ◽  
Abdominal Aorta ◽  
Screening Programme ◽  
Abdominal Aortic Aneurysms ◽  
Aortic Aneurysms ◽  
Ultrasound Scan ◽  
Abdominal Aneurysm ◽  
Abdominal Aortic ◽  
The Uk

This is the second article in a series of articles regarding screening programmes. In this article, an overview of the abdominal aorta is provided. The article also considers the abdominal aortic aneurysm screening programme. Aortic abdominal aneurysm is described. The majority of abdominal aortic aneurysms are asymptomatic; however, if there are any symptoms, these are explained. All four UK countries offer men aged 65 years and over a screening opportunity using an ultrasound scan, the fundamental aspects of abdominal aortic aneurysm screening programmes is offered. It is emphasised that screening is not mandatory in the UK; the man has a right to decline the invitation to attend any screening programme.

OXFORD SCREENING PROGRAMME FOR ABDOMINAL AORTIC ANEURYSM IN MEN AGED 65 TO 74 YEARS

The Lancet ◽  
1988 ◽  
Vol 332 (8611) ◽  
pp. 613-615 ◽  
Author(s):  
Jack Collin ◽  
Jackie Walton ◽  
Leandro Araujo ◽  
David Lindsell
Keyword(s):  
Abdominal Aortic Aneurysm ◽  
Aortic Aneurysm ◽  
Screening Programme ◽  
Abdominal Aortic

scholarly journals Retrospective review of abdominal aortic aneurysm deaths in New Zealand: what proportion of deaths is potentially preventable by a screening programme in the contemporary setting?

BMJ Open ◽  
2019 ◽  
Vol 9 (7) ◽  
pp. e027291
Author(s):  
Wing Cheuk Chan ◽  
Dean Papaconstantinou ◽  
Doone Winnard ◽  
Gary Jackson
Keyword(s):  
Abdominal Aortic Aneurysm ◽  
New Zealand ◽  
Aortic Aneurysm ◽  
Screening Programme ◽  
Population Based ◽  
Cross Sectional ◽  
The People ◽  
Abdominal Aortic ◽  
High Prevalence ◽  
History Of

ObjectivesTo describe the proportions of people dying from abdominal aortic aneurysm (AAA) who might have benefited from a formal screening programme for AAA.DesignRetrospective cross-sectional review of deaths.Setting and study populationsAll AAA deaths registered in New Zealand from 2010 to 2014 in the absence of a national AAA screening programme.Main outcome measuresKnown history of AAA prior to the acute event leading to AAA death, prognosis limiting comorbidities, history of prior abdominal imaging and a validated multimorbidity measure (M3-index scores).Results1094 AAA deaths were registered in the 5 years between 2010 and 2014 in New Zealand. Prior to the acute AAA event resulting in death, 31.3% of the cohort had a known AAA diagnosis, and 10.9% had a previous AAA procedure. On average, the AAA diagnosis was known 3.7 years prior to death. At least 77% of the people dying from AAA also had one or more other prognosis limiting diagnosis. The hazard of 1-year mortality associated with the non-AAA related comorbidities for the AAA cohort aged 65 or above were 1.5–2.6 times higher than to the age matched general population based on M3-index scores. In 2014, overall AAA deaths accounted for only 0.7% of total deaths, and 1.0% of deaths among men aged 65 or above in New Zealand. At most, 20% of people dying from AAA in New Zealand between 2010 and 2014 might have had the potential to derive full benefit from a screening programme. About 51% of cases would have derived no or very limited benefit from a screening programme.ConclusionFalling AAA mortality, and high prevalence of competing comorbidities and/or prior AAA diagnosis and procedure raises the question about the likely value of a national AAA screening programme in a country such as New Zealand.

Abdominal aortic aneurysm disease: health risks, management and screening

Clinical Risk ◽  
2008 ◽  
Vol 14 (6) ◽  
pp. 208-210
Author(s):  
Hany Hafez
Keyword(s):  
Abdominal Aortic Aneurysm ◽  
Aortic Aneurysm ◽  
Health Risks ◽  
Screening Programme ◽  
Non Invasive ◽  
Invasive Test ◽  
Department Of Health ◽  
Abdominal Aortic ◽  
Reduction Of Mortality ◽  
The Impact

Abdominal aortic aneurysm (AAA) disease is a condition that affects mainly men over the age of 65 years. The majority of AAAs will remain asymptomatic and therefore undetected. These undetected aneurysms will invariably grow enough for their walls to rupture leading to death in nearly 75% of those affected. Ultrasound-based AAA screening has been shown to reduce the risk of dying of an AAA by half. This significant reduction of mortality offered by a simple and sensitive non-invasive test has prompted the Department of Health to introduce a national AAA screening programme for England and Wales. In this article, the public health risks of AAA disease together with details of the impact of the anticipated national AAA screening programme are discussed.

Abdominal aortic aneurysm

2017 ◽  
Vol 10 (5) ◽  
pp. 290-296 ◽  
Author(s):  
Suhail Amin Tarafdar ◽  
Mark Xavier Gannon
Keyword(s):  
Abdominal Aortic Aneurysm ◽  
Back Pain ◽  
Aortic Aneurysm ◽  
Surgical Intervention ◽  
Screening Programme ◽  
Ultrasound Screening ◽  
Fatality Rate ◽  
Risk Status ◽  
Abdominal Aortic ◽  
The Uk

An abdominal aortic aneurysm (AAA) is defined as a localised dilation of the abdominal aorta. It tends to occur in men between 65 and 79 years of age, and is more common in smokers. Although frequently asymptomatic, an AAA can cause abdominal, groin or back pain. The fatality rate for ruptured AAAs is 90%. In the UK, an ultrasound screening programme for AAAs is now offered to men aged 65 years and over. Management involves surveillance, optimisation of cardiovascular risk status and surgical intervention. However, patients should also be made aware of the Driver and Vehicle Licensing Authority rules as these may prevent them from driving.

Sign in / Sign up

Export Citation Format

Share Document